AK MEDICAL (01789) announced that its board of directors intends to utilize the share repurchase mandate. Subject to market conditions, the company plans to conduct the proposed share buyback on the open market of The Stock Exchange of Hong Kong Limited from time to time, using up to HK$150 million. The buyback program will continue until the expiration date of the share repurchase authorization. The company intends to fund the proposed share repurchase using its internal financial resources. All repurchased shares are planned to be cancelled upon settlement in accordance with the applicable rules and regulations.